Publication

Article

Oncology & Biotech News
January 2011
Volume 5
Issue 1

These Cells Were Made for Walking

Duke researchers have discovered that the Abl and Arg protein kinases contribute to the formation and activity of invadopodia.

Duke researchers have discovered that the Abl and Arg protein kinases contribute to the formation and activity of invadopodia. Invadopodia are described as foot-like structures that allow cancer cells to travel from the primary tumor to other parts of the body. The invadopodia contain matrix metalloproteinase (MMP), a chemical that creates openings in surrounding tissue that act as an escape hatch of sorts for the cancer cells. Lead author Ann Marie Pendergast said studies should investigate whether Abl/Arg inhibitors would be useful concomitant treatments for patients with cancer to help prevent metastases. Complete findings appear in the December 17 issue of the Journal of Biological Chemistry.

Published in Oncology & Biotech News. January 2011.

Related Videos
Byoung Chol Cho, MD, PhD, professor, internal medicine, Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine
Stephen J. Freedland, MD
Ben Levy, MD, and Yan Leyfman, MD
Viktor Grünwald, MD, PhD
Aaron Gerds, MD
BDTX-1535 – A MasterKey EGFR Inhibitor Targeting Classical, Non-Classical, and the C797S Resistance Mutation To Address The Evolved Landscape Of EGFR Mutant NSCLC
Christine M. Lovly, MD, PhD, Ingram Associate Professor of Cancer Research, associate professor, medicine (hematology/oncology), Vanderbilt-Ingram Cancer Center
Daniel M. Halperin, MD, associate professor, Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
BTK Inhibitors in CLL : Second Generation Drugs and Beyond